Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia만성 림프구성 백혈병 환자에서 mRNA 항-COVID-19 백신 BNT162b2 및 mRNA-1273에 대한 체액 반응Article Published on 2022-01-112022-09-12 Journal: Blood advances [Category] SARS, 진단, [키워드] absence acute respiratory syndrome age anti-CD20 Antibody Response BNT162b2 CLL Combination coronavirus COVID-19 dose evaluate highest Humoral response immune response independent predictor individual inhibitor leukemia monoclonal antibody monotherapy mRNA mRNA-1273 mRNA-1273 vaccine multivariable analysis neutralizing monoclonal antibodies Older Patient post-dose Prophylactic provide receiving response rate risk SARS-CoV-2 second dose Seroconversion seronegative seronegative patient significantly higher single dose therapy treated Treatment treatment-naïve patient tyrosine vaccination Vaccine venetoclax [DOI] 10.1182/bloodadvances.2021006215 PMC 바로가기 [Article Type] Article
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-AnalysisArticle Published on 2022-01-092022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% confidence interval anti-SARS-CoV-2 vaccine Antibody Response antibody response rate appear COVID-19 COVID-19 vaccine demonstrated dose Efficacy Efficacy and safety evaluated inclusion criteria linear mRNA vaccine occurred Patient patients performed proportion Random-effects models Randomized controlled trial recipient recipients reduced reported retrospective review Safe Safety safety profile second dose serologic seronegative severe adverse event Solid solid organ solid organ transplant Solid organ transplant recipients systemic the SARS-CoV-2 third dose Transplant Vaccine vaccine dose Vaccines Web of Science [DOI] 10.3390/vaccines10010095 PMC 바로가기 [Article Type] Article
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks두 번의 COVID-19 발생 후 7개월 동안 장기 요양 시설 입소자의 항 SARS-CoV-2 항체 지속성Immunology Published on 2022-01-032022-09-11 Journal: Frontiers in Immunology [Category] MERS, 진단, 치료법, [키워드] 229E Analysis Anti-nucleocapsid antibodies anti-nucleocapsid antibody Anti-spike antibody antibody levels approved attack rate binding domain Canada Care carried changes in collected comparison COVID-19 COVID-19 outbreak cross reaction demonstrated evaluate finding Gradual HCoV HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 HKU1 human coronavirus human coronavirus (HCoV) humoral humoral immune response Humoral response humoral responses individual individuals Long long term Long term care facilities median MONITOR monitors Month multiplexed immunoassay NL63 nucleocapsid OC43 outbreak Outbreak investigation outbreak investigations Outbreaks over participant participated performed platform provided public health RBD reaction Receptor binding domain Reinfection resident SARS-CoV-2 serologic test serologic testing serologic tests serological serological survey Serological surveys seronegative seropositive seropositive individual serostatus serum serum sample serum samples Seven Spike protein Spike proteins statistical analyses statistically significant survey term the spike protein were used [DOI] 10.3389/fimmu.2021.775420 PMC 바로가기 [Article Type] Immunology
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults젊은 스웨덴 성인에 대한 인구 기반 연구에서 SARS-CoV-2에 특이적인 B 및 T 세포 면역Clinical Trial Published on 2022-01-012022-09-11 Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age allergy assessment Asthma Asymptomatic asymptomatic infections Barn binding domain birth cohort body mass body mass index cellular immunity Characteristics Cohort conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease detectable disease Effects ELISA ELISPOT Factor Follow-up Health humoral humoral and cellular immunity IgA IgE IgG IgG titer IgG titers IgM Immunity IMPROVE indicate individual Infection memory B memory B cells memory response memory T memory T cells Mild mild to moderate mild to moderate disease milieu moderate disease participant population-based cohort positive public transport respiratory rhinitis risk Risk factors SARS-CoV-2 SARS-COV-2 infection seronegative seropositive seropositive subject Seropositivity severe acute respiratory syndrome Coronavirus Sex smoking specific IgM subject subjects subpopulation subset Swedish Symptom symptomatic and asymptomatic T cells T-cell T-cell immunity T-cell Response T-cell responses Transport vaccination whom young adults [DOI] 10.1016/j.jaci.2021.10.014 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 Vaccine Response in People with Multiple Sclerosis다발성 경화증 환자의 코로나19 백신 반응Article Published on 2022-01-012022-09-12 Journal: Annals of neurology [Category] MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval age ANN anti-CD20 anti-CD20 treatment anti-SARS-CoV-2 antibody Blood calculated cellular Cohort coronavirus disease COVID-19 disease drug drug history immune response Logistic regression Lymphocyte count management medical records medications monoclonal antibody Multiple multiple sclerosis not differ Odds ratio Patient predicted provided Quantitative questionnaire recommendation regression modeling response risk SARS-CoV-2 SARS-CoV-2 vaccination sclerosis Seroconversion serological response seronegative significantly subject T cell responses T-cell immunity tested the SARS-CoV-2 therapy Treatment vaccination Vaccine vaccine response [DOI] 10.1002/ana.26251 PMC 바로가기 [Article Type] Article
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study요양원 거주자의 BNT162b2 백신 1회 및 2회 접종 후 항체 반응: CONsort-19 연구Article Published on 2022-01-012022-09-11 Journal: Allergy [Category] SARS, 진단, 치료법, [키워드] Analysis antibodies against SARS-CoV-2 antibody BNT162b2 BNT162b2 vaccine BNT162b2/Pfizer vaccine Chain Reaction COVID-19 COVID-19 infection COVID-19 vaccination diagnosed First wave French higher risk highest humoral immune response IgG IgG antibodies IgG antibody IgG level IgG levels Infection longitudinal study MOST N-protein nucleocapsid nursing home nursing homes Older polymerase chain polymerase chain reaction Post-vaccine Protein RBD IgG Real-time reverse-transcriptase polymerase chain reaction remained resident rRT-PCR RT-PCR S-RBD SARS-CoV-2 seronegative seropositive single vaccine Spike protein symptomatic symptomatic COVID-19 the spike protein vaccination were measured [DOI] 10.1111/all.15007 PMC 바로가기 [Article Type] Article
Mucosal immune response in BNT162b2 COVID-19 vaccine recipientsBNT162b2 COVID-19 백신 수혜자의 점막 면역 반응Clinical Trial Published on 2022-01-012022-09-12 Journal: EBioMedicine [Category] 임상, 진단, [키워드] acquisition activated Antibody titre baseline BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine collected Concentration COVID-19 COVID-19 vaccine Department elicit ELISA entry of SARS-CoV-2 first dose generate healthcare worker highest IgA IgG immune response Immunity increase induce magnitude Medicine mRNA BNT162b2 much higher mucosal neutralizing antibody protocol Quantitative recipient Saliva Sample SARS-CoV-2 second dose seronegative seropositive individual seropositive individuals seropositive subjects serum serum IgG significantly single dose subjects supported surgery systemic immune response titre total antibody Umberto university vaccination vaccine dose virus were measured [DOI] 10.1016/j.ebiom.2021.103788 PMC 바로가기 [Article Type] Clinical Trial
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities장기요양시설 입소자의 SARS-CoV-2-중화항체 동역학Article Published on 2022-01-012022-09-12 Journal: The journal of nutrition, health & aging [Category] SARS, 진단, [키워드] affected Analysis Antibody titer appear BNT162b2 Care Cellular immune response COVID-19 elderly Epidemic evaluate facility Follow-up high risk Immunity immunosenescence Kinetics material median morbidity Mortality NAb titer NAbs neutralization test neutralizing antibody nine nursing homes outbreak participant Particle Patient patients Pfizer positive serology Quantitative remained resident retroviral S glycoprotein SARS-CoV-2 SARS-COV-2 infection Seroconversion serological Serological assay Serological testing seronegative shown significant difference statistically significant susceptible T cell the SARS-CoV-2 virus timepoint university vaccination Vaccination strategy Vaccine [DOI] 10.1007/s12603-021-1713-4 PMC 바로가기 [Article Type] Article
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial일본에서 SARS-CoV-2에 대한 AZD1222(ChAdOx1 nCoV-19)의 면역원성과 안전성: 이중 맹검, 무작위 대조 1/2상 시험Clinical Trial Published on 2022-01-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 임상, 진단, [키워드] acute respiratory syndrome adverse event AEs age antibody Antigen AZD1222 body temperature ChAdOx1 ChAdOx1 nCoV-19 Cohort collected common Coronavirus-2 COVID-19 Day death domain dose double-blind elderly Elderly adult elevated elicited endpoints evaluated fatigue headache humoral immune response Humoral response immunogenicity injection Intramuscular injection Japan Japanese malaise Pain parallel-group participant Participants Placebo placebo-controlled Randomized receive receiving reported SARS-CoV-2 SARS-CoV-2 spike serious AE seronegative severity stratified Trial Vaccine [DOI] 10.1016/j.ijid.2021.10.030 PMC 바로가기 [Article Type] Clinical Trial
Evaluation of neutralizing antibodies after vaccine BNT162b2: Preliminary data백신 BNT162b2 후 중화 항체 평가: 예비 데이터Article Published on 2022-01-012022-09-11 Journal: Journal of Clinical Virology [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome age antibody antibody levels Antibody test appear beta-coronavirus binding BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine carried caused complex coronavirus disease Coronavirus disease 2019 declined detect DiaSorin evaluated female participants female subjects FIVE followed by healthcare humoral immune response IgG IgG antibodies IgG antibody immune immunisation Immunisation safety immunogenicity data increase in individuals infected with SARS-CoV-2 male participant male subject male subjects mean value Neutralizing antibodies neutralizing antibody no significant difference outbreak pandemic plateau reached Receptor binding domain reported respiratory SARS-CoV-2 second dose seronegative Serum level serum levels significant difference statistically significant Surveillance the mean the vaccine two subject Two subjects vaccination Vaccine were infected Wuhan Wuhan, China [DOI] 10.1016/j.jcv.2021.105057 PMC 바로가기 [Article Type] Article